Valuation dashboard for Lixte Biotechnology Holdings, Inc. (LIXT) with P/E N/A, P/B 4.06, EV/EBITDA -30.96 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Lixte Biotechnology Holdings, Inc. is a drug discovery company focused on developing new treatments. It employs biomarker technology to identify crucial enzyme targets associated with serious, widespread diseases, then designs innovative compounds to act upon these targets.
Analysis Summary
Trailing-twelve-month margins: gross margin 0.0%, operating margin 0.0%, net margin 0.0%.
At the current price of $7.21, LIXT has negative trailing earnings (P/E not meaningful) and an ROE of -62.18%. Market capitalisation stands at $89M.
Balance sheet quality for LIXT: current ratio of 3.9. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 4.06 |
| EV / EBITDA | -30.96 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-8.10 |
| vs Current Price | -212.3% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| LIXT | Lixte Biotechnology Holdings, Inc. | $89M | 4.06 | -62.2% | |
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $131.8B | |||
| VRTX | Vertex Pharmaceuticals Incorporated | $130.6B | 29.76 | 6.46 | 23.3% |
| 0R2M.L | Regeneron Pharmaceuticals, Inc. | $84.0B | |||
| REGN | Regeneron Pharmaceuticals, Inc. | $79.8B | 18.79 | 2.57 | 13.8% |
| ARGX | argenx SE | $61.2B | 36.30 | 7.40 | 21.7% |
| MRNA | Moderna, Inc. | $57.8B | 1.34 | -39.2% | |
| RVMD | Revolution Medicines, Inc. | $41.7B | 15.96 | -96.4% |
Price
| Price | $7.21 |
| Market Cap | $89M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -62.18% |
| Return on Invested Capital | -42.33% |
| Return on Assets | -47.19% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Related companies: ALLR · BCTX · CASI · CING · CLSD · ENTO · HOTH
Explore sector: Healthcare · Biotechnology
More sections of LIXT: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks